False Reports on Increase in Prices of Drugs

Image
Delhi
Last Updated : Nov 28 2014 | 4:20 PM IST
The Minister for Chemicals & Fertilisers Shri Ananth Kumar has said that there have been unsubstantiated allegations and reports relating to rise in prices of some essential drugs in the recent past. In reply to a question in the Rajya Sabha today, he said certain political leaders, contrary to the fact, had alleged that prices of some drugs have risen. The minister pointed out that they were alleging that price of a drug package (Imatinib) had increased from 8500 Rupees to over one lakh eight thousand rupees while its actual price always continued to be over 8,400 Rupees. He said the order issued in July reducing the prices of 108 drugs, which includes essential medicines for diabetes and cardio vascular diseases, continues to be valid. Withdrawing an internal guideline in relation to para 19 of DPCO 2013 does not affect these prices, the Minister said.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 28 2014 | 4:20 PM IST

Next Story